Found: 14
Select item for more details and to access through your institution.
Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-34109-8
- By:
- Publication type:
- Article
AKT mutant allele-specific activation dictates pharmacologic sensitivities.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29638-1
- By:
- Publication type:
- Article
Haemophagocytic lymphohistiocytosis in adults: a multicentre case series over 7 years.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 3, p. 412, doi. 10.1111/bjh.13837
- By:
- Publication type:
- Article
A germline JAK2 SNP is associated with predisposition to the development of JAK2<sup>V617F</sup>-positive myeloproliferative neoplasms.
- Published in:
- Nature Genetics, 2009, v. 41, n. 4, p. 455, doi. 10.1038/ng.342
- By:
- Publication type:
- Article
Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00251-7
- By:
- Publication type:
- Article
Convergent evolution of BRCA2 reversion mutations under therapeutic pressure by PARP inhibition and platinum chemotherapy.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, p. 1, doi. 10.1038/s41698-024-00526-9
- By:
- Publication type:
- Article
Clinical and Morphologic Characteristics of Fibroblast Growth Factor Receptor Inhibitor-Associated Retinopathy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A phase Ib dose-escalation and expansion study of the oral MEK inhibitor pimasertib and PI3K/MTOR inhibitor voxtalisib in patients with advanced solid tumours.
- Published in:
- 2018
- By:
- Publication type:
- journal article
NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types.
- Published in:
- British Journal of Cancer, 2022, v. 126, n. 3, p. 514, doi. 10.1038/s41416-021-01536-1
- By:
- Publication type:
- Article
NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Precision oncology: Charting a path forward to broader deployment of genomic profiling.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Phase I Dose-Escalation Study of LY3405105, a Covalent Inhibitor of Cyclin-Dependent Kinase 7, Administered to Patients With Advanced Solid Tumors.
- Published in:
- Oncologist, 2024, v. 29, n. 1, p. e131, doi. 10.1093/oncolo/oyad215
- By:
- Publication type:
- Article
The activity, safety, and evolving role of brigatinib in patients with ALK-rearranged non-small cell lung cancers.
- Published in:
- OncoTargets & Therapy, 2017, v. 10, p. 1983, doi. 10.2147/OTT.S109295
- By:
- Publication type:
- Article
Clinical implications of drug‐induced liver injury in early‐phase oncology clinical trials.
- Published in:
- Cancer (0008543X), 2020, v. 126, n. 22, p. 4967, doi. 10.1002/cncr.33153
- By:
- Publication type:
- Article